San Francisco, CALIFORNIA1 Active Studies

Thyroid Disease Clinical Trials in San Francisco, CALIFORNIA

Find 1 actively recruiting thyroid disease clinical trials in San Francisco, CALIFORNIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
240
Enrolling

Recruiting Thyroid Disease Studies in San Francisco

About Thyroid Disease Clinical Trials in San Francisco

Thyroid disease encompasses conditions that affect the thyroid gland, including hypothyroidism (underactive), hyperthyroidism (overactive), Hashimoto's thyroiditis, and Graves' disease. The thyroid produces hormones that regulate metabolism. Treatment depends on the type and may include medication, radioactive iodine, or surgery.

There are currently 1 thyroid disease clinical trials recruiting participants in San Francisco, CALIFORNIA. These studies are seeking a combined 240 participants. Research is being sponsored by Immunovant Sciences GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.

Thyroid Disease Clinical Trials in San Francisco — FAQ

Are there thyroid disease clinical trials in San Francisco?

Yes, there are 1 thyroid disease clinical trials currently recruiting in San Francisco, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What thyroid disease treatments are being tested?

The 1 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for thyroid disease.

Data updated March 2, 2026 from ClinicalTrials.gov